The EXI1800 is positioned for laboratories that need a stronger specialty-testing platform and a clearer move into structured CLIA workflow.
The EXI1800 is positioned for laboratories that need a stronger specialty-testing platform and a clearer move into structured CLIA workflow.
ZYBIO EXI1800 CLIA analyzer positioning in Ethiopia for automated immunoassay and specialty test workflow.
Suitable for laboratories evaluating an organized entry point into automated immunoassay testing.
Relevant where institutions need cleaner routing into thyroid, fertility and other hormone-oriented workflows.
Provides a structured CLIA route inside Berhan Pharma’s wider diagnostic portfolio.
Key reasons this family matters during procurement, deployment planning, and technical review.
Helps buyers evaluate automated immunoassay separately from routine chemistry and POCT.
Aligned with high-interest specialty test areas in clinical laboratory planning.
Useful for institutions broadening service menus and strengthening in-house specialty testing.
Pairs naturally with chemistry and hematology in complete laboratory planning.
Quick comparison points used during technical review, model shortlisting, and quotation alignment.
Structured specialty-testing platform for hormone, thyroid, fertility, and related immunoassay workflows.
Useful when evaluating specialty-test turnaround for hospital and diagnostic-center workflows.
Procurement teams should confirm final configuration and menu availability during quotation.
Sample suitability depends on the assay menu and local reagent configuration.
How institutions usually frame this product family during department-level planning and quotation review.
Suitable for institutions strengthening in-house immunoassay capability.
Useful for laboratories adding broader specialty menus and more structured CLIA workflow.
Supports comparison around specialty testing role rather than forcing a generic analyzer discussion.
Cross-links inside the product family for faster comparison and navigation.
